Unintentional sulfonylurea toxicity due to a drug–drug interaction: a case report
Abstract Background Sulfonylureas are widely used for type 2 diabetes mellitus, but these medications carry a risk of hypoglycemia. Drug–drug interactions that inhibit sulfonylurea metabolism and thus increase systemic exposure can cause unintentional sulfonylurea toxicity. Case presentation A 56-ye...
Main Authors: | Keith Gunaratne, Emily Austin, Peter E. Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-05-01
|
Series: | BMC Research Notes |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13104-018-3404-8 |
Similar Items
-
Network-Based Methods for Prediction of Drug-Target Interactions
by: Zengrui Wu, et al.
Published: (2018-10-01) -
Identification of New Toxicity Mechanisms in Drug-Induced Liver Injury through Systems Pharmacology
by: Aurelio A. Moya-García, et al.
Published: (2022-07-01) -
Hydroxyzine‐induced fixed drug eruption and cross‐reaction with oxatomide
by: Mizuki Terada, et al.
Published: (2023-04-01) -
Toxicological Findings in a Possible Drug-drug Interaction Death: A Case Report
by: Mohammed Y. Albeishy, et al.
Published: (2021-02-01) -
Editorial: Drug-drug interactions in pharmacology
by: Simona Pichini, et al.
Published: (2023-02-01)